Bank of New York Mellon’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.84M | Buy |
219,661
+4,618
| +2% | +$38.6K | ﹤0.01% | 2997 |
|
|
2026
Q1 | $1.78M | Sell |
215,043
-29,469
| -12% | -$305K | ﹤0.01% | 2867 |
|
|
2025
Q4 | $3.02M | Buy |
244,512
+91,174
| +59% | +$977K | ﹤0.01% | 2615 |
|
|
2025
Q3 | $1.35M | Buy |
153,338
+12,025
| +9% | +$93.5K | ﹤0.01% | 3034 |
|
|
2025
Q2 | $902K | Buy |
141,313
+124,310
| +731% | +$711K | ﹤0.01% | 3184 |
|
|
2025
Q1 | $82.6K | Buy |
17,003
+4,894
| +40% | +$40.5K | ﹤0.01% | 4021 |
|
|
2024
Q4 | $116K | Hold |
12,109
| – | – | ﹤0.01% | 4021 |
|
|
2024
Q3 | $101K | Buy |
+12,109
| New | +$110K | ﹤0.01% | 4007 |
|
|
2024
Q2 | – | Sell |
-170,029
| Closed | -$430K | – | 4166 |
|
|
2024
Q1 | $430K | Sell |
170,029
-7,158
| -4% | -$16.1K | ﹤0.01% | 3620 |
|
|
2023
Q4 | $425K | Sell |
177,187
-62,171
| -26% | -$146K | ﹤0.01% | 3641 |
|
|
2023
Q3 | $814K | Sell |
239,358
-244,219
| -51% | -$1.35M | ﹤0.01% | 3284 |
|
|
2023
Q2 | $3.55M | Sell |
483,577
-20,462
| -4% | -$190K | ﹤0.01% | 2504 |
|
|
2023
Q1 | $5.22M | Sell |
504,039
-19,641
| -4% | -$237K | ﹤0.01% | 2281 |
|
|
2022
Q4 | $6.18M | Buy |
523,680
+41,516
| +9% | +$642K | ﹤0.01% | 2206 |
|
|
2022
Q3 | $10.1M | Buy |
482,164
+390
| +0.1% | +$10.9K | ﹤0.01% | 1897 |
|
|
2022
Q2 | $15M | Sell |
481,774
-107,505
| -18% | -$3.67M | ﹤0.01% | 1702 |
|
|
2022
Q1 | $24.2M | Sell |
589,279
-1,608
| -0.3% | -$70.9K | ﹤0.01% | 1540 |
|
|
2021
Q4 | $25.7M | Sell |
590,887
-3,301
| -0.6% | -$149K | ﹤0.01% | 1575 |
|
|
2021
Q3 | $29.8M | Buy |
594,188
+71,731
| +14% | +$4.34M | 0.01% | 1480 |
|
|
2021
Q2 | $32.9M | Buy |
522,457
+17,163
| +3% | +$1.1M | 0.01% | 1442 |
|
|
2021
Q1 | $46.9M | Sell |
505,294
-14,922
| -3% | -$1.53M | 0.01% | 1149 |
|
|
2020
Q4 | $46.6M | Sell |
520,216
-18,214
| -3% | -$1.67M | 0.01% | 1084 |
|
|
2020
Q3 | $55.6M | Sell |
538,430
-1,258
| -0.2% | -$136K | 0.01% | 858 |
|
|
2020
Q2 | $42.7M | Buy |
539,688
+10,146
| +2% | +$756K | 0.01% | 979 |
|
|
2020
Q1 | $30.6M | Sell |
529,542
-24,149
| -4% | -$1.39M | 0.01% | 1031 |
|
|
2019
Q4 | $29.9M | Sell |
553,691
-29,458
| -5% | -$1.6M | 0.01% | 1319 |
|
|
2019
Q3 | $30.5M | Sell |
583,149
-24,353
| -4% | -$1.13M | 0.01% | 1260 |
|
|
2019
Q2 | $29.3M | Sell |
607,502
-169,489
| -22% | -$8.12M | 0.01% | 1307 |
|
|
2019
Q1 | $39.3M | Sell |
776,991
-20,603
| -3% | -$1.22M | 0.01% | 1117 |
|
|
2018
Q4 | $47.3M | Sell |
797,594
-54,246
| -6% | -$3.5M | 0.01% | 929 |
|
|
2018
Q3 | $56.1M | Buy |
851,840
+95,892
| +13% | +$5.6M | 0.01% | 939 |
|
|
2018
Q2 | $38.2M | Buy |
755,948
+16,801
| +2% | +$875K | 0.01% | 1183 |
|
|
2018
Q1 | $38.9M | Buy |
739,147
+165,697
| +29% | +$8.26M | 0.01% | 1147 |
|
|
2017
Q4 | $26.6M | Buy |
573,450
+19,105
| +3% | +$804K | 0.01% | 1404 |
|
|
2017
Q3 | $22.4M | Sell |
554,345
-12,133
| -2% | -$439K | 0.01% | 1491 |
|
|
2017
Q2 | $19.2M | Buy |
566,478
+9,181
| +2% | +$283K | 0.01% | 1577 |
|
|
2017
Q1 | $16.2M | Sell |
557,297
-155,631
| -22% | -$4.74M | ﹤0.01% | 1669 |
|
|
2016
Q4 | $23.4M | Buy |
712,928
+27,734
| +4% | +$831K | 0.01% | 1437 |
|
|
2016
Q3 | $21.6M | Buy |
685,194
+14,876
| +2% | +$432K | 0.01% | 1418 |
|
|
2016
Q2 | $18.8M | Sell |
670,318
-682,704
| -50% | -$26.8M | 0.01% | 1441 |
|
|
2016
Q1 | $49.2M | Sell |
1,353,022
-504,712
| -27% | -$17.8M | 0.01% | 870 |
|
|
2015
Q4 | $74.3M | Sell |
1,857,734
-514,288
| -22% | -$17.9M | 0.02% | 676 |
|
|
2015
Q3 | $67.6M | Sell |
2,372,022
-396,630
| -14% | -$13.1M | 0.02% | 699 |
|
|
2015
Q2 | $91.2M | Sell |
2,768,652
-160,298
| -5% | -$4.97M | 0.03% | 624 |
|
|
2015
Q1 | $84.2M | Buy |
2,928,950
+23,618
| +0.8% | +$677K | 0.02% | 665 |
|
|
2014
Q4 | $79.1M | Sell |
2,905,332
-434,931
| -13% | -$10.4M | 0.02% | 674 |
|
|
2014
Q3 | $71.2M | Sell |
3,340,263
-45,133
| -1% | -$1.03M | 0.02% | 702 |
|
|
2014
Q2 | $76M | Buy |
3,385,396
+22,488
| +0.7% | +$524K | 0.02% | 697 |
|
|
2014
Q1 | $85M | Buy |
3,362,908
+181,850
| +6% | +$4.59M | 0.02% | 634 |
|
|
2013
Q4 | $73.1M | Sell |
3,181,058
-139,044
| -4% | -$2.9M | 0.02% | 693 |
|
|
2013
Q3 | $63.2M | Sell |
3,320,102
-100,400
| -3% | -$1.79M | 0.02% | 743 |
|
|
2013
Q2 | $49.3M | Buy |
+3,420,502
| New | +$49.5M | 0.02% | 832 |
|
Other funds holding EBS
PGCM
PAM
VFA
WAM
Bank of New York Mellon's EBS Position: Q2 2026 in Review
Bank of New York Mellon increased its Emergent Biosolutions (EBS) stake by 2.1% in Q2 2026, buying an estimated $38.6K and bringing the position to 219,661 shares worth $1.84M. The position accounts for ﹤0.01% of the portfolio, ranked #2997.
Bank of New York Mellon first reported a position in EBS in Q2 2013 and has held it in 52 quarters since. The position peaked at $91.2M in Q2 2015. 78 funds tracked by Wall St. Rank hold EBS as of Q2 2026.
- Bank of New York Mellon held 219,661 shares of Emergent Biosolutions worth $1.84M as of Q2 2026.
- Bank of New York Mellon bought 4,618 Emergent Biosolutions shares in Q2 2026, an estimated $38.6K.
- Emergent Biosolutions made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2997 holding.
- Bank of New York Mellon first reported a position in Emergent Biosolutions in Q2 2013 and has held it in 52 quarters since.
- Bank of New York Mellon's Emergent Biosolutions position peaked at $91.2M in Q2 2015.
- 78 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.